NVO
$127.86
Revenue | $65349Mn |
Net Profits | $25407Mn |
Net Profit Margins | 38.88% |
PE Ratio | 45.32 |
Novo Nordisk A/s’s revenue jumped 22.45% since last year same period to $65349Mn in the Q1 2024. On a quarterly growth basis, Novo Nordisk A/s has generated -0.78% fall in its revenue since last 3-months.
Novo Nordisk A/s’s net profit jumped 28.23% since last year same period to $25407Mn in the Q1 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 15.68% jump in its net profits since last 3-months.
Novo Nordisk A/s’s net profit margin jumped 4.72% since last year same period to 38.88% in the Q1 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 16.59% jump in its net profit margins since last 3-months.
Novo Nordisk A/s’s price-to-earnings ratio after this Q1 2024 earnings stands at 45.32.
EPS Estimate Current Quarter | 0.87 |
EPS Estimate Current Year | 0.87 |
Novo Nordisk A/s’s earning per share (EPS) estimates for the current quarter stand at 0.87 - a 18.76% jump from last quarter’s estimates.
Novo Nordisk A/s’s earning per share (EPS) estimates for the current year stand at 0.87.
Earning Per Share (EPS) | 0.83 |
Return on Assets (ROA) | 0.25 |
Return on Equity (ROE) | 1 |
Dividend Per Share (DPS) | 0.93 |
Novo Nordisk A/s’s earning per share (EPS) jumped 31.75% since last year same period to 0.83 in the Q1 2024. This indicates that the Novo Nordisk A/s has generated 31.75% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Novo Nordisk A/s’s return on assets (ROA) stands at 0.25.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Novo Nordisk A/s’s return on equity (ROE) stands at 1.
Novo Nordisk A/s declared 0.93 dividend per share during the earnings announcement for Q1 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-31 | 0.77 | 0.83 | 7.79% |